PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model: Molecular Therapy - Oncolytics
JPM | Free Full-Text | Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages | HTML
Regenerative medicine: curing rather than simply treating diseases - Healthcare industry
Gene Therapy Getting Personal: Mutation-Specific Editing and Gene Addition Strategies for β-Thalassaemia: Hemoglobin: Vol 43, No 6
Cancers | Free Full-Text | An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells
CMN Webinar - CRISPR Off-Targets , June 23rd 2021
News: CAST-Seq: A New and Much-Needed Tool for Assessing the Safety of Designer Nucleases - CRISPR Medicine
Gene and Cell Therapy e-School | OncologyPRO
IJMS | Free Full-Text | Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
IJMS | Free Full-Text | Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors
![HIV-1 promoter is gradually silenced when integrated into BACH2 in Jurkat T-cells [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/10321/1/fig-4-full.png "HIV-1 promoter is gradually silenced when integrated into BACH2 in Jurkat T-cells [PeerJ]")
HIV-1 promoter is gradually silenced when integrated into BACH2 in Jurkat T-cells [PeerJ]
Team:Freiburg/HP/Gold Integrated - 2017.igem.org
News: CAST-Seq: A New and Much-Needed Tool for Assessing the Safety of Designer Nucleases - CRISPR Medicine
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells: Molecular Therapy - Methods & Clinical Development
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells: Molecular Therapy - Methods & Clinical Development
It's an Unequivocal Win for Us” — Office of University and Science Communications
Annual Biomedical Scientific Congress at NUS - Posts | Facebook
New Frontiers for Patient Care: The Intersection of Inherited Disease, Gene Therapy, and HSCT
News: CMN Webinar Catch Up: CRISPR Off-Targets - CRISPR Medicine
Automated generation of gene-edited CAR T cells at clinical scale: Molecular Therapy - Methods & Clinical Development
The RESTORE Momentum Workshop - RESTORE
IJMS | Free Full-Text | Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors | HTML
JPM | Free Full-Text | Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants | HTML
News: CMN Webinar Catch Up: CRISPR Off-Targets - CRISPR Medicine
Automated generation of gene-edited CAR T cells at clinical scale. - Abstract - Europe PMC
CMN Webinar - CRISPR Off-Targets , June 23rd 2021
